Page last updated: 2024-09-02

deguelin and benzyloxycarbonylleucyl-leucyl-leucine aldehyde

deguelin has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 2 studies

Compound Research Comparison

Studies
(deguelin)
Trials
(deguelin)
Recent Studies (post-2010)
(deguelin)
Studies
(benzyloxycarbonylleucyl-leucyl-leucine aldehyde)
Trials
(benzyloxycarbonylleucyl-leucyl-leucine aldehyde)
Recent Studies (post-2010) (benzyloxycarbonylleucyl-leucyl-leucine aldehyde)
18201152,47331,057

Protein Interaction Comparison

ProteinTaxonomydeguelin (IC50)benzyloxycarbonylleucyl-leucyl-leucine aldehyde (IC50)
Proteasome subunit beta type-11Homo sapiens (human)1.9893
Calpain-9Homo sapiens (human)9.88
Proteasome subunit alpha type-7Homo sapiens (human)1.9893
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus3.9
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 23.8999
AromataseHomo sapiens (human)0.044
Indoleamine 2,3-dioxygenase 1Homo sapiens (human)0.5
Proteasome subunit beta type-1Homo sapiens (human)1.0853
Proteasome subunit alpha type-1Homo sapiens (human)1.9893
Proteasome subunit alpha type-2Homo sapiens (human)1.9893
Proteasome subunit alpha type-3Homo sapiens (human)1.9893
Proteasome subunit alpha type-4Homo sapiens (human)1.9893
Proteasome subunit beta type-8Homo sapiens (human)1.9893
Proteasome subunit beta type-9Homo sapiens (human)1.9893
Proteasome subunit alpha type-5Homo sapiens (human)1.9893
Proteasome subunit beta type-4Homo sapiens (human)1.9893
Proteasome subunit beta type-6Homo sapiens (human)1.9893
Proteasome subunit beta type-5Homo sapiens (human)0.6088
Proteasome subunit beta type-10Homo sapiens (human)1.9893
Proteasome subunit beta type-3Homo sapiens (human)1.9893
Proteasome subunit beta type-2Homo sapiens (human)2.0443
Proteasome subunit alpha type-6Homo sapiens (human)1.9893
Proteasome subunit alpha-type 8Homo sapiens (human)1.9893
Proteasome subunit beta type-7Homo sapiens (human)1.9893

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hong, WK; Jeong, JW; Jin, Q; Kang, HJ; Kim, KW; Lee, HY; Oh, SH; Woo, JK1
Feng, B; Mu, J; Qi, W; Tang, JY; Wei, Y; Wu, Q; Yang, LL; Zeng, W; Zhang, Q1

Other Studies

2 other study(ies) available for deguelin and benzyloxycarbonylleucyl-leucyl-leucine aldehyde

ArticleYear
Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
    International journal of cancer, 2008, Jan-01, Volume: 122, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Animals, Genetically Modified; Aorta; Blotting, Western; Cell Hypoxia; Cell Movement; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Collagen; Culture Media, Conditioned; Cysteine Proteinase Inhibitors; Drug Combinations; Endothelium, Vascular; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Laminin; Leupeptins; Luciferases; Mice; Neoplasms; Neovascularization, Pathologic; Proteasome Endopeptidase Complex; Proteoglycans; Reverse Transcriptase Polymerase Chain Reaction; Rotenone; Tumor Cells, Cultured; Ubiquitin; Vascular Endothelial Growth Factor A; Zebrafish

2008
MG132 protects against renal dysfunction by regulating Akt-mediated inflammation in diabetic nephropathy.
    Scientific reports, 2019, 02-14, Volume: 9, Issue:1

    Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glomerular Mesangium; Glucose; Humans; Inflammation; Inflammation Mediators; Kidney; Leupeptins; Male; Mesangial Cells; Proteasome Inhibitors; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Rotenone; Signal Transduction

2019